Sort
48,018 grants matching “immunotherapy”
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
$451,366Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$451,326Andrea Facciabene · University Of Pennsylvania · R01 · FY2018 · CA
Modeling immunity with a hybrid lymph node tissue-chip
$451,321Rebecca R Pompano · University Of Virginia · R01 · FY2021 · AI
Calreticulin-mediated protein folding in health and disease
$451,310Malini Raghavan · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Synthetic Studies Related to Cancer Research/Treatment
$451,239Paul Wender · Stanford University · R01 · FY2016 · CA
Role of Tumor in Therapeutic Response and Resistance
$451,222Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2013 · CA
Mechanisms underlying combination therapy mobilizing NK cells
$451,192David H Raulet · University Of California Berkeley · R01 · FY2024 · CA
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
$451,162Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Antigenic Determinants on HLA-B7 and -A2
$451,153Victor H. Engelhard · University Of Virginia · R01 · FY2010 · CA
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$451,126Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2022 · NS
Dust Mite, Cockroach and Cat Allergens: Asthma
$451,114Thomas A. Platts-Mills · University Of Virginia · R01 · FY2006 · AI
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
$451,069Marcus E Peter · Northwestern University At Chicago · R01 · FY2023 · CA
Epigenetic regulation of exhausted CD8 T cells via the miR-29a-TET2 axis
$451,004Erietta Stelekati · University Of Miami School Of Medicine · R01 · FY2025 · AI
Deciphering the mechanism of response to novel HPV-specific viral immune therapy in HPV associated head and neck cancer
$451,000Evgeny (eugene) G Izumchenko · University Of Chicago · R21 · FY2025 · DE
Rescue T cell aging to improve CAR T cell production for elderly cancer patients
$451,000Tuoqi Wu · Ut Southwestern Medical Center · R21 · FY2025 · AG
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$450,986Stephen Matthew Hatfield · Northeastern University · R01 · FY2023 · EB
Computational Analysis of TCR Load Propagation and Dynamics
$450,895Wonmuk Hwang · Dana-Farber Cancer Inst · P01 · FY2025 · AI
Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML
$450,830Anupriya Agarwal · Oregon Health & Science University · U54 · FY2019 · CA
Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCC
$450,789Xiao-Jing Wang · University Of California At Davis · R01 · FY2022 · DE
Project 4: Genomic Predictors of Early Relapse in Immunochemotherapy-Treated Follicular Lymphoma
$450,776James R Cerhan · University Of Iowa · P50 · FY2017 · CA
Amyloid-Lowering Small Molecule AB-Binding Agents in AD
$450,738William E Klunk · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · AG
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
$450,736Paul Michael Armistead · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
An innovative integrated computational framework using gene signatures for patient stratification
$450,696Chao Cheng · Baylor College Of Medicine · R01 · FY2025 · CA
Project 1: Targeting the Neutrophil Lineage To Enhance Immune Checkpoint Inhibitor Efficacy in NSCLC
$450,659A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2020 · CA
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
$450,615Scott S Zamvil · University Of California, San Francisco · R01 · FY2019 · AI